참고문헌
- Bunger S, Laubert T, Roblick UJ, et al (2011). Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J Cancer Res Clin Oncol, 137, 375-89. https://doi.org/10.1007/s00432-010-0965-x
- Chen W, Abnet CC, Wei WQ, et al (2004). Serum markers as predictors of esophageal squamous dysplasia and early cancer. Anticancer Res, 24, 3245-9.
- Ferguson MK, Martin TR, Reeder LB, et al (1997). Mortality after esophagectomy: risk factor analysis. World J Surg, 2, 599-603.
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-7. https://doi.org/10.1002/ijc.25516
- Jiang H, Wang XH, Yu XM, et al (2012). Detection and prognostic analysis of serum protein expression in esophageal squamous cell cancer. Asian Pac J Cancer Prev, 13, 1579-82. https://doi.org/10.7314/APJCP.2012.13.4.1579
- Kunisaka C, Makino I, Kimura J, et al (2010). Impact of lymphnode metastasis site in patients with thoracic esophageal cancer. J Surg Oncol, 101, 36-42. https://doi.org/10.1002/jso.21425
- Kuusela P, Haglund C, Roberts PJ (1991). Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer, 63, 636-40. https://doi.org/10.1038/bjc.1991.146
- Lerut TE, de Leyn P, Coosemans W, et al (1994). Advanced esophageal carcinoma. World J Surg, 18, 379-87. https://doi.org/10.1007/BF00316818
- Mao WM, Zheng WH, Ling ZQ (2011). Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev, 12, 2461-6.
- Mirinezhad SK, Somi MH, Jangjoo AG, et al (2012). Survival rate and prognostic factors of esophageal cancer in east Azerbaijan province, North-west of Iran. Asian Pac J Cancer Prev, 13, 3451-4. https://doi.org/10.7314/APJCP.2012.13.7.3451
- Rana S, Dutta U, Kochhar R, et al (2012). Evaluation of CA 242 as a tumor marker in gallbladder cancer. J Gastrointest Cancer, 43, 267-71. https://doi.org/10.1007/s12029-011-9288-7
- Rice TW, Rusch VW, Ishwaran H, et al (2010). Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals. Cancer, 116, 3763-73. https://doi.org/10.1002/cncr.25146
- Vallbohmer D, Lenz HJ (2006). Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus, 19, 425-32. https://doi.org/10.1111/j.1442-2050.2006.00622.x
피인용 문헌
- Combination of FDG PET/CT and Contrast-Enhanced MSCT in Detecting Lymph Node Metastasis of Esophageal Cancer vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7719
- Tumor Markers for Diagnosis, Monitoring of Recurrence and Prognosis in Patients with Upper Gastrointestinal Tract Cancer vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10267